Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
about
P1343
Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT)Enhancement of CIITA transcriptional function by ubiquitinExpression regulation of major histocompatibility complex class I and class II encoding genesHistone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formationStable protein, unstable plaque?Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoterZXDC, a novel zinc finger protein that binds CIITA and activates MHC gene transcriptionTRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradationPML promotes MHC class II gene expression by stabilizing the class II transactivatorThe zinc finger proteins ZXDA and ZXDC form a complex that binds CIITA and regulates MHC II gene transcriptionMutations in NALP12 cause hereditary periodic fever syndromesThe insulator factor CTCF controls MHC class II gene expression and is required for the formation of long-distance chromatin interactionsRole for RFX transcription factors in non-neuronal cell-specific inactivation of the microtubule-associated protein MAP1A promoterRFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiencyInterleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytesThe class II trans-activator CIITA interacts with the TBP-associated factor TAFII32SIRT1 links CIITA deacetylation to MHC II activationA novel cysteine-rich sequence-specific DNA-binding protein interacts with the conserved X-box motif of the human major histocompatibility complex class II genes via a repeated Cys-His domain and functions as a transcriptional repressorThe CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signalsNLR family member NLRC5 is a transcriptional regulator of MHC class I genesDimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor alpha promoter through activation and repression domains.New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis studyThe bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes.STAT 5 and NF-Y are involved in expression and growth hormone-mediated sexually dimorphic regulation of cytochrome P450 3A10/lithocholic acid 6beta-hydroxylaseCIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivationAssociations and interactions between bare lymphocyte syndrome factorsClass II transactivator: mastering the art of major histocompatibility complex expressionMutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complexA functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-YFunction of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-YThe HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase IIBasophils function as antigen-presenting cells for an allergen-induced T helper type 2 responseThe nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activityThe NLR gene family: a standard nomenclatureThe human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzymeATP binding by monarch-1/NLRP12 is critical for its inhibitory functionFunctional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expressionMurine NFX.1: isolation and characterization of its messenger RNA, mapping of its chromosomal location and assessment of its developmental expressionSpecific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein
P2860
Q22011094-5405BD9F-D444-4ABB-BAA9-7E2D4100152EQ22330796-981D91E7-870C-4693-B902-51A00855297CQ24273365-ACD14C31-D033-4133-A486-F5337760BA16Q24289051-94376C16-17DC-4CB3-8FC3-E73BFDAD31E0Q24289391-372E5AF8-F9AE-4C3A-8A57-9D9C50E8703CQ24289417-AEBEC35B-80AC-4696-823E-7FD9DAB8D0ACQ24289418-CAAC44E4-6C95-45B6-A122-C5561F5EE312Q24294243-3C04F9E1-D910-4691-8B49-613344B080B4Q24299467-46730FB2-C405-420A-8DC8-86AA6362118CQ24305248-C953AE44-1E8C-414C-89EF-F65D942AC629Q24308730-938F44D3-24E6-4268-BD8A-AED470AAF2C4Q24312117-99B622C1-6F21-422B-83E0-33F596B3CD30Q24314851-E40ECA34-98EC-41C4-9799-6CE14B62246AQ24315739-0FC14090-8419-4A76-B9D3-ABA3EE1091A4Q24317219-07CDA1CA-13EC-4635-AF2C-6C9340867FB3Q24336213-1C582163-8699-4590-8206-8C15D488CFBFQ24337223-FAC47692-6CBE-4AB7-A3AF-48E01A035F00Q24337320-24D1367A-016D-4F6A-8ECA-659FFD203286Q24337585-16CDBB00-113F-49CE-A429-9F1185242994Q24338949-3C84A159-69CE-4ED9-AC4F-FA1AEC229CE7Q24517594-1A2EDD0D-4C34-49F0-B57E-F467A75AABE0Q24534865-ED0C7182-2B96-4B58-AE10-EA35E3D12422Q24540091-86F1C803-3070-4C1A-9236-3458AA1C33FFQ24547781-E9E358F0-5906-4B38-ABE5-43B83D4890A7Q24551176-0B292DD7-4C4C-4B7D-889A-491221C43E0DQ24551773-2A49A9D8-4DF4-4CB2-A747-09985E11A564Q24552298-96437F48-9682-444E-AE1F-4C3198796C84Q24554195-9DCD4256-EEBF-4621-820B-25314AF64DD6Q24554232-3855DF64-DB6B-4A9E-A29A-5369CEA23985Q24562002-6C3E3867-AB6A-4E8B-8B11-558C51AF8955Q24605935-ACBE9E2B-95D9-4313-8B47-4C2F8DD4AA94Q24613860-EC0C08C3-58D4-4757-973D-D4DE40D745D9Q24629389-78A9B506-DA48-4FA8-9939-20D0C91C6582Q24645445-C2E0A5E6-716F-4A6A-B442-639B142EAFAAQ24646774-F58C3461-C0B4-48F6-9F53-DD24542A3302Q24658100-AE2372CD-7645-4284-AE77-A5219451E42FQ24678821-25E61C29-C32B-4DB8-8F47-D9905D2007ECQ24682778-FF32A004-9BEE-4F76-B3CA-0482B3847D9DQ24683275-7F3EE5DF-E87A-486B-B467-372311526B62Q24683287-D210EB66-38F4-4AF8-B8BF-0C5320893B37
P2860
Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
description
1993 nî lūn-bûn
@nan
1993 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Complementation cloning of an ...... (or bare lymphocyte syndrome)
@ast
Complementation cloning of an ...... (or bare lymphocyte syndrome)
@en
Complementation cloning of an ...... (or bare lymphocyte syndrome)
@en-gb
Complementation cloning of an ...... (or bare lymphocyte syndrome)
@nl
type
label
Complementation cloning of an ...... (or bare lymphocyte syndrome)
@ast
Complementation cloning of an ...... (or bare lymphocyte syndrome)
@en
Complementation cloning of an ...... (or bare lymphocyte syndrome)
@en-gb
Complementation cloning of an ...... (or bare lymphocyte syndrome)
@nl
prefLabel
Complementation cloning of an ...... (or bare lymphocyte syndrome)
@ast
Complementation cloning of an ...... (or bare lymphocyte syndrome)
@en
Complementation cloning of an ...... (or bare lymphocyte syndrome)
@en-gb
Complementation cloning of an ...... (or bare lymphocyte syndrome)
@nl
P2093
P921
P3181
P1433
P1476
Complementation cloning of an ...... (or bare lymphocyte syndrome)
@en
P2093
P304
P3181
P356
10.1016/0092-8674(93)90685-J
10.1016/S0092-8674(05)80090-X
P407
P4510
P577
1993-10-08T00:00:00Z